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Summary  (139 words) 55 
 56 
The transcription factor STAT5 is fundamental to the mammalian immune system. However, the 57 
relationship between its two paralogs, STAT5A and STAT5B, and the extent to which they are 58 
functionally distinct, remains uncertain. Using mouse models of paralog deficiency, we 59 
demonstrate that they are not equivalent for CD4+ 'helper' T cells, the principal orchestrators of 60 
adaptive immunity. Instead, we find that STAT5B is dominant in both effector and regulatory 61 
(Treg) responses and, therefore, uniquely necessary for immunological tolerance. Comparative 62 
analysis of genomic distribution and transcriptomic output reveals that STAT5B has greater 63 
transcriptional output but, surprisingly, our data point towards asymmetric expression (i.e. 64 
paralog dose), rather than distinct functional properties, as the key distinguishing feature. Thus, 65 
we propose a quantitative model of STAT5 paralog activity whereby relative abundance 66 
imposes functional specificity (or dominance) in the face of widespread structural homology. 67 
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Introduction 68 
 69 
Signal Transducers and Activators of Transcription (STAT) family proteins are an evolutionarily 70 
conserved set of transcription factors which operate downstream of cytokine and hormone 71 
receptors to convert extracellular stimuli into biochemical signals that instruct gene expression 72 
(Villarino et al. 2015; Stark and Darnell 2012). In mammals, STAT5 is unique because it is 73 
encoded by two genes, termed Stat5a and Stat5b, derived from a relatively recent duplication 74 
event (Wang and Levy 2012). In fact, the ancestral STAT5 gene appears to have duplicated on 75 
two separate occasions during vertebrate evolution. Once in teleosts, resulting in two paralogs 76 
on different chromosomes, and again in eutherians, resulting in the two contiguous mammalian 77 
paralogs (Liongue et al. 2012).  78 
 79 
Because of their recent divergence, STAT5A and STAT5B are homologous at the DNA, RNA 80 
and protein levels, which has led to persisting questions about whether they are redundant or 81 
functionally distinct. Genetically engineered mice lacking Stat5a or Stat5b have provided 82 
compelling evidence for both arguments. On one hand, there are phenotypic differences; 83 
Stat5a-deficient mice exhibit poor mammary function (Liu et al. 1997), reduced hematopoietic 84 
stem cell proliferation (S. Zhang et al. 2000) and diminished antibody class switching (Kagami et 85 
al. 2000), while Stat5b-deficient mice exhibit dwarfism (Udy et al. 1997), more pronounced 86 
lymphopenia, and greater defects in cytokine-driven lymphocyte proliferation (Moriggl, Sexl, et 87 
al. 1999; Imada et al. 1998). On the other hand, deletion of Stat5a and Stat5b has comparable 88 
effects on some physiological processes, such as eosinophil recruitment (Kagami et al. 2000), 89 
and the most dramatic phenotypes, such as infertility, anemia and perinatal lethality, are evident 90 
only in mice lacking both paralogs, which implies redundancy and/or cooperativity (Teglund et 91 
al. 1998; Socolovsky et al. 1999; Cui et al. 2004). Genome-wide DNA-binding profiles also 92 
support both viewpoints. The target repertoires for STAT5A and STAT5B mostly overlap, which 93 
implies redundancy, but there are also a subset of sites that may be differentially bound, which 94 
implies specificity (Liao et al. 2008; Liao et al. 2011; Yamaji et al. 2013; Kanai et al. 2014). 95 
Consistent with the latter point, humans with germline mutations in STAT5B exhibit a range of 96 
clinical abnormalities, indicating that STAT5A cannot compensate for some vital functions 97 
(Kanai, Jenks, and Nadeau 2012). 98 
 99 
Compound STAT5 deficiency manifests striking immunological abnormalities in mice, most 100 
notably lymphopenia, splenomegaly and autoimmunity. These are typically attributed to its role 101 
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downstream of the common gamma chain (ɣc) receptor and its dedicated Janus kinase, Jak3 102 
(Moriggl, Topham, et al. 1999; Snow et al. 2003; Yao et al. 2006). The ɣc is shared by 6 103 
different cytokines, IL-2 IL-4, IL-7, IL-9, IL-15 and IL-21, each of which employs a unique co-104 
receptor subunit that determines which cell types can be influenced (Rochman, Spolski, and 105 
Leonard 2009). ɣc cytokines impact all lymphocytes but have been most extensively studied in 106 
CD4+ 'helper' T cells, the key orchestrators of adaptive immunity. Among the many functions 107 
ascribed to the ɣc-STAT5 axis in this lineage are the ability to promote Th1- and Th2-type 108 
effector responses, to support T cell memory, to promote activation-induced cell death, to 109 
suppress Th17-type and T follicular helper cell (Tfh) responses, and to promote T regulatory cell 110 
(Treg) responses (Moriggl, Topham, et al. 1999; Liao et al. 2008; Liao et al. 2011; Dooms et al. 111 
2007; J. Zhu et al. 2003; Kagami et al. 2001; Lenardo 1991; Laurence et al. 2007; Ballesteros-112 
Tato et al. 2012; Johnston et al. 2012; Mahmud, Manlove, and Farrar 2013).  113 
 114 
To assess redundancy between STAT5 paralogs, we developed a mouse model where STAT5A 115 
and/or STAT5B were reduced but not absent, allowing us to compare their respective functions 116 
while avoiding the confounding lymphopenia associated with complete STAT5 deficiency. These 117 
studies reveal STAT5B as the dominant paralog in helper T cells; exhibiting far greater impact 118 
on pathogenic effector and host-protective regulatory responses and, therefore, uniquely 119 
required for immunological tolerance. Surprisingly, genome-wide DNA binding and 120 
transcriptome surveys did not uncover widespread differences in target gene selection but, 121 
instead, point towards relative abundance as the key distinguishing factor. Thus, we propose 122 
that asymmetric expression (i.e. paralog dose), rather than differential function, determines the 123 
dominant STAT5 paralog in lymphoid cells.  124 
125 
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Results 126 
 127 
A dominant role for STAT5B in immunological tolerance 128 
 129 
To investigate the relationship between STAT5A and STAT5B, we generated a series of mice 130 
with pre-determined combinations of Stat5 alleles, ranging from two alleles each of A and B (4 131 
total) to one allele of either A or B (Figure 1A)(Yamaji et al. 2013). We refer to each genotype 132 
according to the total number of Stat5 alleles that are retained. For example, two-allele Stat5a-133 
deficient mice lack both Stat5a alleles but retain two of Stat5b (Stat5a-/- Stat5b+/+), while one-134 
allele Stat5a-deficient mice lack both Stat5a alleles and retain just one of Stat5b (Stat5a-/- 135 
Stat5b+/-). All 8 genotypes were born at the expected Mendelian ratios and survived beyond 6 136 
months of age, thereby demonstrating that a single allele of either paralog is sufficient to 137 
prevent the perinatal lethality seen in STAT5-null mice (Data not shown)(Hoelbl et al. 2006; Cui 138 
et al. 2004). Red blood cell counts and hematocrits were comparable across all genotypes, 139 
indicating that a single allele is also enough to support erythropoiesis, but white blood cell 140 
(WBC) counts were sharply reduced in one-allele Stat5a- or Stat5b-deficient mice, as well as 141 
two-allele Stat5b-deficient mice. By contrast, two-allele Stat5a-deficient mice had relatively 142 
normal WBC counts (Figure 1B).  143 
 144 
None of the STAT5 mutants exhibited histological abnormalities in the liver, spleen or intestine, 145 
tissues known to be affected in STAT5-null mice (Data not shown)(Snow et al. 2003; Yao et al. 146 
2006). However, Stat5b-deficient mice did exhibit kidney pathology with a penetrance of 75% or 147 
25%, depending on whether they harbored one or two Stat5a alleles (Figure 1C). Afflicted 148 
individuals presented a loss of glomerular structure, proteinuria and systemic anti-DNA 149 
antibodies (Figure 1D-F). Therefore, as in humans, Stat5b is required for immunological 150 
tolerance in mice but, given the clear difference between having one or two Stat5a alleles, 151 
redundancy and/or cooperativity is also evident. 152 
 153 
STAT5 paralog dose governs T follicular helper cell responses 154 
 155 
To probe for immunological phenotypes, we first assessed the cellularity and composition of 156 
primary lymphoid organs. Although not completely lymphopenic like STAT5-null mice (Yao et al. 157 
2006), one- and two-allele Stat5b-deficient mice did have fewer splenocytes than WT controls 158 
(Figure 2A). Cell counts were also reduced in one-allele Stat5a-deficient mice, suggesting that, 159 
while STAT5B may be dominant, STAT5A does have substantial influence. Lymph node 160 
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cellularity was similarly affected by the loss of either paralog and, in fact, all genotypes with less 161 
than three-alleles had reduced cell counts (Figure 2A).  162 
 163 
Frequencies of CD4+ T cells were comparable across all genotypes, whereas CD8+ T cells were 164 
reduced in one-allele Stat5b-deficient mice and, to a lesser extent, in one-allele Stat5a-deficient 165 
mice (Figure 2B). By contrast, B cells were increased in one-allele Stat5b-deficient mice and, 166 
consistent with the appearance of auto-antibodies, GL7+ Fashigh IgDlow germinal center (GC) B 167 
cells were dramatically enriched (Figure 2B-C and data not shown). One-allele Stat5a-168 
deficient mice had a more modest accumulation of GC B cells, again, illustrating both the 169 
relevance and redundancy of STAT5A (Figure 2B-C). 170 
 171 
The ability to promote B cell responses is a defining characteristic of CD4+ ‘helper’ T cells 172 
(Crotty 2011). Therefore, given the appearance of GC B cells, we next investigated the CD4+ T 173 
cell compartment. Not surprisingly, there was a marked accumulation of CD44high IL-7Rαlow 174 
effector/memory T cells in Stat5b-deficient mice which, as with the incidence of kidney disease, 175 
was more pronounced in those bearing one-allele of Stat5a than in those bearing two (Figure 176 
3A-B & Figure 3-figure supplement 1A). We also measured production of IFN-ɣ and IL-17, 177 
two effector cytokines that are dysregulated in STAT5-null mice (Laurence et al. 2007). IFN-ɣ+ 178 
cells were highly enriched in the autoimmune-prone Stat5b-deficient mice but not age-matched 179 
Stat5a-deficient counterparts, suggesting that STAT5B may be particularly important for limiting 180 
Th1-type responses. IL-17A+ Th17-type cells were also increased but this trend did not reach 181 
statistical significance (Figure 3C-D).  182 
 183 
CD4+ Tfh cells specialize in promoting B cell responses (Crotty 2011). Mirroring the abundance 184 
of GC B cells, there was dramatic accumulation of  PD1high CXCR5high ICOShigh Tfh cells in one-185 
allele Stat5b-deficient mice, and a more modest enrichment in one-allele Stat5a-deficient mice  186 
(Figure 3E-F, Figure 3-figure supplement 1B & data not shown). At least two interpretations 187 
can be made for this disparity; either the two proteins are not functionally equivalent or the two 188 
genes have different outputs. Consistent with the latter view, mice lacking one-allele each of 189 
Stat5a and Stat5b (i.e. double-heterozygotes) had more Tfh cells than those lacking two-alleles 190 
of Stat5a, despite having the same total number of alleles. Moreover, the percentage of Tfh 191 
cells was comparable between two-allele Stat5b-deficient mice and one-allele Stat5a-deficient 192 
mice, suggesting that two alleles of Stat5a are roughly equal to one allele of Stat5b (Figure 3F 193 
& Figure 3-figure supplement 1B).  194 
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STAT5 paralog dose impacts multiple aspects of regulatory T cell function 195 
 196 
CD4+ T regulatory (Treg) cells expressing the forkhead transcription factor, FOXP3, are 197 
essential for immunological tolerance (Malek and Castro 2010). Given the importance of STAT5 198 
in Treg cells (Mahmud, Manlove, and Farrar 2013), we next inspected this subset. Unlike 199 
STAT5-null mice, which exhibit a profound lack of Treg cells (Yao et al. 2007; Burchill et al. 200 
2006), frequencies of splenic FOXP3+ cells were relatively normal across our STAT5 mutants. 201 
However, due to differences in overall cellularity, absolute counts were significantly lower in 202 
one- and two-allele Stat5b-deficient mice, as well one-allele Stat5a-deficient mice. A similar 203 
trend was observed for LN resident Treg cells; frequencies were comparable to WT controls but 204 
total numbers were reduced in all genotypes bearing less than 3 total alleles (Figure 4-figure 205 
supplement 1). To further characterize the Treg compartment, we measured IL-2Rα, a 206 
component of the IL-2 receptor that is critical for Treg cell homeostasis and function. It is also a 207 
both upstream and downstream of STAT5 signaling and, thus, can be viewed as an indicator of 208 
STAT5 activity (Malek and Castro 2010). We found that the percentage of IL-2Rα+ Treg cells 209 
mirrored the total number of Stat5 alleles; it was slightly reduced in mice with three alleles, lower 210 
in those with 2, and lower still in those with 1 (Figure 4A-B). We also noted that residual IL-211 
2Rα+ Treg cells from one-allele mice had reduced suppressive capacity and were unable to 212 
maintain expression of IL-2Rα during in vitro culture (Figure 4C-E). Each of these phenotypes 213 
was more pronounced in the absence of Stat5b than Stat5a, again, illustrating both the 214 
dominance of the former and the relevance (and/or redundancy) of the latter.  215 
 216 
Given the appearance of IFN-ɣ+ effector T cells in Stat5b-deficient mice, we next asked whether 217 
Stat5b-deficient Treg cells express TBX21, a transcription factor required for Treg cells to limit 218 
Th1-type responses (Koch et al. 2009). Similar to conventional T cells (Liao et al. 2011), we 219 
found that IL-2 was sufficient to induce TBX21 in WT Treg cells (Figure 4F). This effect was 220 
slightly reduced in the absence of Stat5a but almost completely abolished in the absence of 221 
Stat5b, consistent with the disparity of other STAT5-dependent parameters (e.g. Tfh cell and 222 
Treg cell responses). Both Stat5a- and Stat5b-deficient Treg cells maintained FOXP3 223 
expression similar to WT controls and, surprisingly, both gained the ability to produce IL-2, a 224 
cytokine that is typically restricted in this lineage (Figure 4F-G).     225 
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STAT5 is required for in vitro differentiation of induced regulatory (iTreg) T cells (Yao et al. 226 
2007). To dissect the contributions of STAT5A and STAT5B, we purified naive CD4+ T cells from 227 
our STAT5 mutants, cultured them under iTreg polarizing conditions and compared expression 228 
of FOXP3. We found that, although both paralogs appear to play a role, STAT5B has far greater 229 
influence on iTreg generation - see the striking reduction of FOXP3+ cells in one-allele Stat5b-230 
deficient cultures (Figure 5A). We also found that deletion of either paralog endowed FOXP3+ 231 
iTreg cells with the ability to produce IL-2, which suggests that, beyond its effects on 232 
differentiation, STAT5 may also limit the inflammatory potential of this subset (Figure 5A-B).  233 
 234 
Next, we compared the transcriptomes of Stat5a- and Stat5b-deficient T cells cultured under 235 
iTreg polarizing conditions. Gene set enrichment analysis revealed that the overall Treg gene 236 
signature - defined by a combination of FOXP3- and IL-2-dependent transcriptional programs 237 
(Hill et al. 2007) - was similarly affected in both genotypes, meaning that there were no broad 238 
qualitative differences (Figure 5C). However, there were obvious quantitative differences; 239 
several key genes, including Foxp3 and Il2ra, were more impacted by the loss of STAT5B than 240 
STAT5A (Figure 5D). Thus, while both paralogs can impact multiple aspects Treg cell biology, 241 
deletion of Stat5b is clearly more disruptive, befitting its dominant station within immunological 242 
tolerance.  243 
 244 
Specificity and redundancy of STAT5 paralogs for gene transcription 245 
 246 
To define the molecular basis for phenotypic differences between Stat5a- and Stat5b-deficient T 247 
cells, we employed a bioinformatic approach. First, we compared their transcriptomes either 248 
directly ex vivo or after acute exposure to STAT5-activating stimuli. The ex vivo set included 249 
naive T cells and Treg cells, while the in vitro set included naive T cells cultured with IL-7 and 250 
effector T cells cultured with IL-2 (Figure 6A & Figure 6-figure supplement 1A). These 251 
pairings were chosen to match the expression patterns of requisite χc co-receptors; IL-7R, 252 
which is highly expressed on naive T cells, and IL-2Rα, which is highly expressed on effector T 253 
cells (Rochman, Spolski, and Leonard 2009). One-allele mice were used because they 254 
exhibited the most dramatic T cell phenotypes. 255 
 256 
We began our transcriptomic survey by performing multidimensional scaling of the datasets, 257 
thereby gaining a broad overview of the experimental groups. Stat5a- and Stat5b-deficient cells 258 
typically clustered together and equidistant from WT controls, suggesting that the loss of either 259 
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paralog has comparable genome-wide effects (Figure 6-figure supplement 1B). Next, we used 260 
statistical variance to identify differentially expressed genes. Surprisingly, we found widespread 261 
discord between Stat5a- and Stat5b-deficient cells; many transcripts appeared dysregulated in 262 
the absence of one paralog or the other (Figure 6-figure supplement 1C-D). However, upon 263 
close inspection, we concluded that the disparity was largely due to the fold-change cutoff that 264 
was chosen. Most genes that were designated as STAT5B-specific were also affected by the 265 
loss of STAT5A (and vice versa), albeit to a lesser degree that did not reach the arbitrary 2-fold 266 
threshold (Figure 6-figure supplement 1E). To avoid this statistical artifact, we devised a 267 
‘paralog preference’ scale whereby all STAT5-sensitive genes were compiled and ranked 268 
according to how much they were impacted by the loss of Stat5a or Stat5b. This analysis 269 
revealed a binomial distribution for all experimental conditions. The majority of genes were in 270 
central bins, affected by both STAT5A and STAT5B, while membership in peripheral bins 271 
decreased steadily as paralog preference increased. Importantly, all curves were shifted 272 
towards STAT5B, suggesting that STAT5-sensitive genes are generally more impacted by 273 
STAT5B than STAT5A (Figure 6B). This latter trend was also evident at the protein level; IL-2-274 
driven (but not IL-6-driven) induction of IL-2Rα was clearly more diminished in Stat5b-deficient 275 
cells than in Stat5a-deficient counterparts (Figure 6E). Collectively, these data affirm that 276 
STAT5B is dominant over STAT5A while, at the same time, demonstrating pervasive 277 
redundancy at the level of gene transcription.  278 
 279 
Beyond quantitative differences, our transcriptomic survey also revealed qualitative differences 280 
between Stat5a- and Stat5b-deficient cells. Using strict analysis criteria, we discovered that 281 
between 12% and 22% of all STAT5-sensitive genes can be classified as paralog-specific, 282 
meaning that they are solely dependent on either STAT5A or STAT5B. The absolute number of 283 
paralog-specific genes varied across cell states and stimuli, with the largest allotment found in 284 
IL-7-treated naive cells, and was typically skewed towards STAT5B (Figure 6C & Figure 6-285 
figure supplement 1E). Thus, we can create 2 general categories: ‘pan-STAT5' genes that are 286 
regulated by both STAT5A and STAT5B (e.g. Pdk1, Cish, Lta) and 'paralog specific' genes that 287 
are regulated by either STAT5A (e.g. Smc6) or STAT5B (e.g. Cd74)(Figure 6D & Figure 6-288 
figure supplement 2). Given that pan-STAT5 genes are much more numerous, we propose 289 
that phenotypic differences between Stat5a and Stat5b deficient T cells are due largely to 290 
paralog preference, owing to the fact that deletion of Stat5b has greater quantitative impact, with 291 
limited contribution from paralog-specific effects.   292 
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Paralog dose dictates genome wide distribution of STAT5   293 
 294 
Functional divergence between STAT5A and STAT5B could be due to differences in target 295 
gene selection. Previous studies have addressed this issue by comparing genomic distributions 296 
by ChIP-seq (chromatin immunoprecipitation followed by massively parallel sequencing) using 297 
separate, paralog-specific antibodies in WT T cells (Liao et al. 2008; Liao et al. 2011; Kanai et 298 
al. 2014). We took an alternative approach involving a single antibody that recognizes both 299 
paralogs and T cells from Stat5a- or Stat5b-deficient mice, as well as ‘double heterozygotes’ 300 
(hereafter referred to as Stat5a/bhet mice). Stringent peak calling identified 1275 unique regions 301 
of STAT5 occupancy in WT cells, consistent with prior inquiries (Figure 7A). By contrast, 302 
Stat5a/bhet cells had fewer peaks (658 total; Figure 7A) that tended to be less robust (i.e. lower 303 
signal intensity) than those found in WT controls (Figure 7D), indicating that changes in STAT5 304 
availability can impact genomic distribution even when both paralogs are present. Total peaks 305 
were also reduced in Stat5a-deficient cells (609 total) and almost expunged in Stat5b-deficient 306 
cells (97 total), again, illustrating both the relevance of the former and the dominance of the 307 
latter (Figure 7A). STAT5 peaks were similarly localized across all genotypes - they typically 308 
congregated near transcriptional start sites but could also be found at distal regions, sometimes 309 
>100 kb from annotated genes - and were highly enriched for STAT-binding motifs (Figure 7B 310 
& Figure 7-figure supplement 1).  311 
 312 
Most peaks found in Stat5b-deficient cells could be matched to peaks in Stat5a-deficient, 313 
Stat5a/bhet or WT cells (Figure 7C). This implies a hierarchy whereby certain sites are 314 
preserved even when STAT5B is absent. STAT5B-independent peaks tended to occur near 315 
genes that were highly occupied in WT controls and whose expression was highly dysregulated 316 
in Stat5b-deficient cells (e.g. Cish, Lta), suggesting that only the most robust (i.e. high-affinity) 317 
STAT5 binding sites were preserved (Figure 8). Peaks detected within Stat5a/bhet and Stat5a-318 
deficient cells also tended to be highly occupied in WT controls and dysregulated in STAT5-319 
deficient cells, but the trend was not as dramatic, indicating that, while a full complement of 320 
STAT5 alleles may be necessary to achieve optimal responses, STAT5B has the greatest 321 
influence on genomic distribution (Figure 8).    322 
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Among the genes that were engaged by STAT5 in WT cells and dysregulated in Stat5-deficient 323 
cells was Il2ra, which, as discussed, is a known STAT5 target gene that is critical for Treg 324 
function and homeostasis (Figure 7E & Figure 7-figure supplement 2). Another was Bcl6, 325 
considered the master transcription factor for Tfh differentiation (Crotty 2011)(Figure 7E & 326 
Figure 7-figure supplement 2). In this case, STAT5 binding appears to be a negative 327 
regulatory event; multiple studies (including the present work) have shown that STAT5 can 328 
suppress Bcl6 expression in T cells (Oestreich, Mohn, and Weinmann 2012; Liao et al. 2014). 329 
Thus, taken together, our RNA-seq and ChIP-seq data provide a molecular rationale for the 330 
Treg and Tfh phenotypes seen in Stat5-deficient mice. 331 
 332 
Asymmetric expression of STAT5 paralogs in helper T cells 333 
 334 
Based on our RNA-seq studies, we reasoned that asymmetric expression, rather than 335 
widespread paralog-specific activity, likely explains the phenotypic differences between Stat5a- 336 
and Stat5b-deficient T cells. To explore this possibility, we mined various transcriptome datasets 337 
(including our own) and found that, indeed, Stat5b is more abundant than Stat5a at the mRNA 338 
level (Figure 9-figure supplement 1). Next, we used flow cytometry to measure total STAT5 339 
protein in naive, regulatory (Treg), follicular (Tfh) and effector/memory T cells. Regardless of 340 
cellular subset, the results were clear: removing one-allele of Stat5b (Stat5a+/+ Stat5b+/-) had 341 
greater impact than removing one-allele of Stat5a (Stat5a+/+ Stat5b+/-) and, correspondingly, 342 
retaining one-allele of Stat5b (Stat5a-/- Stat5b+/-) was far more beneficial than retaining one-343 
allele of Stat5a (Stat5a+/- Stat5b-/-)(Figure 9A). A similar trend was observed for tyrosine-344 
phosphorylated STAT5 upon exposure to IL-2 or IL-7 (Figure 9B). Thus, we conclude that 345 
STATB makes a greater contribution to the total STAT5 protein pool. 346 
 347 
To determine how STAT5 availability (i.e. paralog dose) influences gene expression, we 348 
transduced Stat5b-deficient T cells with a STAT5A-expressing retrovirus, thereby increasing the 349 
total amount of STAT5 without re-introducing STAT5B, then measured transcription by RNA-350 
seq. We first validated the system by measuring Il2ra, a well-documented STAT5 target, and 351 
found it to be highly induced at both the mRNA and protein levels (Figure 10A). Overall, ectopic 352 
STAT5A mobilized 320 genes, most of which fall within the pan-STAT5 category (e.g. Cish, 353 
Lta)(Figure 10A-B). When applied to our paralog preference scale, these genes did not favor 354 
STAT5A, meaning that they were similarly affected in Stat5a- and Stat5b-deficient cells (Figure 355 
10A). In addition, GSEA revealed a high degree of enrichment for both STAT5A- or STAT5B-356 
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dependent gene sets (Figure 10C). Taken together, these data support the idea that differing 357 
STAT5 protein concentrations underlie many (if not most) of the transcriptomic divergence 358 
between Stat5a- and Stat5b-deficient cells.   359 
 360 
Having established that ectopic STAT5A can rescue gene expression in Stat5b-deficient T cells, 361 
we next asked whether it can rescue iTreg differentiation. For these studies, naive T cells from 362 
wild type, Stat5a/bhet or one-allele Stat5b-deficient mice were cultured under iTreg polarizing 363 
conditions, then transduced with either control or STAT5A retrovirus and FOXP3 measured to 364 
assess lineage commitment. FOXP3 induction was greatly reduced in control-transduced 365 
Stat5a/bhet cells and almost completely abolished in control-transduced Stat5b-deficient cells 366 
(Figure 10D). However, when ectopic STAT5A was introduced, the percentage of FOXP3+ cells 367 
was comparable across all genotypes and, whether endogenous (top row) or ectopic (bottom 368 
row), there was a clear linear correlation between STAT5 and FOXP3 protein levels (Figure 369 
10D). IL-2Rα, another key STAT5 target, was also diminished in Stat5a/bhet and Stat5b-370 
deficients cells, and restored by ectopic STAT5A (Figure 10E). Collectively, these data argue 371 
that a threshold concentration of STAT5 must be reached to institute the Treg program and, 372 
given the conspicuous effect of ectopic STAT5A on WT cells (Figure 10D & Figure 10-figure 373 
supplement 1A), they imply that availability of STAT5 is a limiting factor in this process.  374 
 375 
Although they share a common instructive cytokine (TGF-β), Th17 cells and Treg cells have 376 
opposing pro- and anti-inflammatory functions. STAT5 is key to this divergence - it promotes 377 
Treg responses at the expense of Th17 responses – so we next investigated the effect of 378 
paralog dose on Th17-type responses. First, we found that the percentage of IL-17+ cells was 379 
4-fold higher in Stat5a/bhet Th17 cultures and >25-fold higher in Stat5b-deficient Th17 cultures 380 
than in WT controls, consistent with a high paralog dose threshold. More importantly, we found 381 
that ectopic STAT5 not only extinguished IL-17 but also induced FOXP3 in all genotypes, 382 
thereby demonstrating that changes in STAT5 concentration can tip the balance between 383 
effector and regulatory T cells programs (Figure 10-figure supplement 1B).   384 
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Discussion 385 
 386 
Although the importance of STAT5 is widely recognized, there is no consensus on whether its 387 
closely related paralogs, STAT5A and STAT5B, are redundant or functionally distinct. Assuming 388 
the latter, it is also unclear how specificity would be achieved given their extensive structural 389 
homology. Both positions are grounded in sound experimental evidence but, until the present 390 
studies, there has been no comprehensive inquiry on their relationship in immune cells. We 391 
addressed this longstanding question in primary CD4+ helper T cells, the principal orchestrators 392 
of adaptive immunity. Using a combination of genetic and genomic approaches, we 393 
demonstrate that STAT5B is dominant over STAT5A and, thus, plays a non-redundant role in 394 
controlling effector and regulatory T cell responses. This conclusion is based on phenotypic 395 
differences between Stat5a- and Stat5b-deficient mice, as well as bioinformatic analyses 396 
showing that STAT5B has greater impact on both selection and transcription of STAT5 target 397 
genes. The disparity does not appear to be due to differences in genome wide distribution or 398 
transcriptional capacity but, instead, relates to differences in relative abundance. Consistent 399 
with the latter point, our loss- and gain-of-function studies demonstrate that a threshold 400 
concentration of STAT5 must be reached to execute STAT5-dependent gene expression and 401 
differentiation programs. Based on these findings, we submit that STAT5A and STAT5B are 402 
largely redundant at the molecular level, but not at the cellular or organismal levels, where 403 
STAT5B is dominant due to increased availability.  404 
 405 
It has been proposed that the target repertoires of STAT5A and STAT5B vary due to subtle 406 
differences in the amino acid composition of their DNA-binding domains (Boucheron et al. 407 
1998). However, this notion has been disputed because the nature and location of these 408 
changes may not alter protein structure enough to impact specificity. In addition, multiple studies 409 
have shown that the consensus DNA binding motifs for STAT5A and STAT5B are identical, 410 
although it should be noted that these measured optimal binding to synthetic oligonucleotides in 411 
cell free systems, leaving open the possibility that divergent binding properties become 412 
apparent only at lower affinity sites or in the context of native chromatin (Soldaini et al. 1999; 413 
Ehret et al. 2001). Indeed, differential binding of STAT5A or STAT5B has been detected at 414 
several loci in primary immune cells but it remains unclear whether this reflects bona fide 415 
differences in specificity or other factors that may influence target gene selection (Liao et al. 416 
2008; Liao et al. 2011; Yamaji et al. 2013; Kanai et al. 2014). For instance, it is known that 417 
STAT5A and STAT5B can exhibit distinct phosphorylation patterns, so preferential binding may 418 
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reflect cell type- or stimulus-specific differences in activation rather than distinct targeting 419 
capabilities (Caldenhoven et al. 1998; Hennighausen and Robinson 2008; Rosen et al. 1996; 420 
Meinke et al. 1996). Our work supports this latter view by establishing that, even before 421 
activation, relative abundance of STAT5A versus STAT5B determines which paralog will 422 
dominate a given transcriptional response. 423 
 424 
Recent work has shown that small oscillations in transcription factor availability can have 425 
genome-wide consequences (Brewster et al. 2014). The idea that STAT5 concentration can 426 
impact cellular function also has precedent. Of particular interest are studies reporting severe 427 
immunological phenotypes in transgenic mice which over-express STAT5A or STAT5B (Kelly, 428 
Spolski, Kovanen, et al. 2003; Kelly, Spolski, Imada, et al. 2003), and studies showing that 429 
Stat5a/b haplo-insufficiency ameliorates contact hypersensitivity (Nivarthi et al. 2014). In 430 
addition, we have previously demonstrated that ectopic STAT5A can expand the target 431 
repertoire of STAT5 in mouse embryonic fibroblasts (B. M. Zhu et al. 2012), and have explored 432 
the concept of STAT5 gene dosage in the context of mammary development, finding that a high 433 
STAT5 threshold must be reached for mammary epithelial cell differentiation (Yamaji et al. 434 
2013). Given that STAT5A is the dominant paralog in mammary epithelium, we can infer that 435 
asymmetric expression of STAT5 paralogs is not just a feature of immune cells, and that it must 436 
be controlled in a tissue-specific manner (Metser et al. 2016). Several mechanisms may explain 437 
this phenomenon. First, it is known that Stat5a and Stat5b are transcribed from opposite DNA 438 
strands and, thus, may be subject to strand-specific modes of regulation (Figure 9-figure 439 
supplement 2). Second, differential transcription could be achieved through paralog-specific 440 
enhancer elements whose accessibility is tissue- and/or cell type-restricted. We have recently 441 
characterized an intergenic enhancer that drives expression of Stat5a in mammary epithelium 442 
and have identified multiple DNase hypersensitivity sites within the Stat5b locus that are present 443 
in T cells but not in non-lymphoid tissues, perhaps indicating an analogous mechanism for 444 
immune cells (Metser et al. 2016)(Figure 9-figure supplement 3). Third, paralog-specific 445 
epigenetic modifications, such as histone or DNA methylation, may impose distinct 446 
transcriptional outputs, as shown for tumor cells (Q. Zhang et al. 2007). Fourth, the 3’ UTRs of 447 
Stat5a and Stat5b are highly divergent so it is possible that their mRNAs are subject to post-448 
transcriptional regulation via distinct sets of microRNAs and/or RNA-binding proteins (Liu et al. 449 
1995).  450 
 451 
Beyond asserting the dominance of STAT5B, our work also affirms the importance of STAT5A. 452 
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Several observations support this latter point: 1) deletion of one Stat5a allele exaggerates the 453 
gross and cellular phenotypes of Stat5b-deficient mice, 2) transcription of STAT5 target genes is 454 
typically influenced by both STAT5A or STAT5B, and 3) ectopic STAT5A can rescue gene 455 
expression in Stat5b-deficient cells. Furthermore, just one-allele of either Stat5a or Stat5b is 456 
sufficient to prevent the perinatal lethality and anemia seen in STAT5-null mice, suggesting that 457 
molecular redundancy protects the most critical ‘life-and-death’ functions. We also identified a 458 
small subset of genes that appear to be regulated by either STAT5A or STAT5B, some of which 459 
have known immunological functions. Given that STAT5B is more abundant, it can be argued 460 
that all STAT5B-dependency may be due to a high paralog dose threshold, but this cannot 461 
explain the appearance of STAT5A-dependent genes. Thus, we propose that phenotypic 462 
differences between Stat5a- and Stat5b-deficient T cells result from widespread ‘paralog 463 
preference’ and circumscribed 'paralog specificity'. 464 
 465 
Our ChIP-seq studies indicate that the overall availability of STAT5, whether STAT5A or 466 
STAT5B, has profound influence on target gene selection. Previous studies have compared 467 
genomic distribution of STAT5A and STAT5B in primary CD4+ T cells and found that they 468 
mostly overlap, thereby supporting the idea of redundancy (Liao et al. 2008; Liao et al. 2011; 469 
Kanai et al. 2014). However, they also identified a subset of sites that are occupied by one 470 
paralog or the other and, thus, have been taken as evidence for paralog specificity. All such 471 
comparisons (including ours) should be interpreted with care. Shared sites can be appointed 472 
with confidence but, due to technical confounders (e.g. differences in antibody affinity), 473 
incongruent sites cannot be definitively classified as STAT5A- or STAT5B-specific. The 474 
mechanisms underlying differential binding must also be considered. It is possible that bona fide 475 
paralog-specific binding sites do exist, but these are probably only a minor fraction. In most 476 
cases, differential binding likely reflects competition; the more abundant paralog is more likely to 477 
be detected. Given this nuance, claims that certain genes are uniquely regulated by STAT5A or 478 
STAT5B should be tempered. For instance, it has been suggested that Bcl2l1 is regulated only 479 
by STAT5A and that Bcl2, Il2ra and Foxp3 are regulated only by STAT5B (Kanai et al. 2014; 480 
Jenks et al. 2013). Our data indicate that these are more accurately described as 'pan-STAT5' 481 
genes that are more impacted by deletion of one paralog or the other. 482 
  483 
STAT5 is essential for immunological tolerance (Mahmud, Manlove, and Farrar 2013). This 484 
principle is well illustrated in humans with congenital STAT5B defects, who typically manifest a 485 
range of autoimmune symptoms (Kanai, Jenks, and Nadeau 2012), and is further supported by 486 
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the present work, which demonstrates that Stat5b deficiency leads to spontaneous kidney 487 
disease in mice. The link between STAT5 and autoimmunity is often attributed to its role 488 
downstream of IL-2/IL-2Rα in Treg cells (Malek and Castro 2010; Mahmud, Manlove, and Farrar 489 
2013). Our work clearly endorses this viewpoint and brings to mind the autoimmune phenotype 490 
of Treg-deficient Scurfy mice which, like Stat5b-deficient mice, exhibit both autoantibodies and 491 
kidney disease {Aschermann:2013gn}. We demonstrate that, similar to STAT5B-deficient 492 
humans (Cohen et al. 2006), Treg cells are functionally compromised in Stat5b-deficient mice, 493 
but, surprisingly, the baseline frequency of FOXP3+ cells was not reduced, likely reflecting 494 
immunological and/or environmental differences between the two species. We also present new 495 
ideas about why STAT5-deficient Treg cells are impaired. First, they acquire the ability to 496 
produce IL-2, a cytokine that is typically restricted in Treg cells (Malek and Castro 2010). This 497 
finding is consistent with previous studies demonstrating that STAT5 can suppress IL-2 498 
production by conventional T cells and, given that Treg cells are thought to operate, in part, by 499 
consuming IL-2, it provides one explanation for their ineffectiveness (Villarino et al. 2007; 500 
Pandiyan et al. 2007). Second, they fail to express TBX21, a transcription factor that is required 501 
to limit Th1-type T cell responses (Koch et al. 2009). Previous studies have shown that STAT1-502 
activating cytokines (e.g. interferons, IL-27) can induce TBX21 in Treg cells but we are the first 503 
to show that IL-2, a STAT5-activating cytokine, can do it (Hall et al. 2012; Koch et al. 2012). 504 
 505 
Aside from its role in Treg cells, STAT5 promotes immunological tolerance via effector cell-506 
intrinsic mechanisms. Given the dramatic accumulation of Tfh cells in our STAT5 mutants, the 507 
capacity of Tfh cells to promote autoimmunity, and recent work showing that STAT5 can 508 
suppress Tfh differentiation (Ballesteros-Tato et al. 2012; Johnston et al. 2012), we conclude 509 
that exaggerated Tfh responses factor heavily in the autoantibody responses and attendant 510 
kidney pathology seen in Stat5b-deficient mice. Our data also suggest an intimate relationship 511 
between STAT5 and BCL6, the ‘master’ transcription factor for Tfh cells. We report that STAT5 512 
directly engages the Bcl6 locus, where it likely acts as a transcriptional repressor, and that 513 
STAT5 binding sites are often enriched for BCL6 motifs, consistent with published accounts of 514 
co-localization between these two transcription factors (Y. Zhang, Laz, and Waxman 2012; Liao 515 
et al. 2014). These findings strongly implicate Tfh cells in the pathogenesis of Stat5b-deficient 516 
mice but, since these are germline ‘knockouts’, we must consider the (likely) possibility that 517 
intrinsic defects in other cell types contribute to the autoimmune phenotype. For instance, 518 
multiple dendritic cell subsets are known to be dysregulated in Stat5- or Jak3-deficient mice 519 
(Esashi et al. 2008; Yamaoka 2005), and its influence on non-immune cells, particularly 520 
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downstream of hormone receptors, cannot be ignored (Kuhrt and Wojchowski 2015; 521 
Hennighausen and Robinson 2008). 522 
 523 
Because of its prominent role within the immune system, STAT5 has long been viewed as an 524 
attractive target for therapeutic intervention. Clinical use of STAT5-activating cytokines and 525 
growth factors (e.g. IL-2, erythropoetin) is now commonplace and the recent approval of Jak3 526 
inhibitors for the treatment of autoimmune disease and malignancy points to sustained interest 527 
in this pathway (Villarino et al. 2015). Consequently, a detailed understanding of how STAT5 528 
signaling works is imperative not only to inform new drugs, but also to improve existing 529 
regimens. The present study yields multiple clinically relevant insights and, in particular, raises 530 
two key issues that should be considered. First, partial inhibition of STAT5 expression and or 531 
activity may be sufficient to have desired effects on immune cell function. Second, targeting of 532 
STAT5A may be safer (though perhaps less robust) than targeting of STAT5B. Therefore, taking 533 
a broad view, our findings provide a molecular rationale for exploiting STAT5 paralog 534 
redundancy in clinical settings.  535 
536 
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Materials & Methods 537 
 538 
Experimental Animals 539 
 540 
STAT5 mutants were generated as described (Yamaji et al. 2013). Briefly, mice lacking the 541 
entire Stat5 locus (Stat5a/b+/-) were crossed with mice lacking one-allele of Stat5a (Stat5a+/- 542 
Stat5b+/+) or Stat5b (Stat5a+/+ Stat5b+/-) to produce 8 combinations of Stat5 alleles (Figure 1A). 543 
We refer to each genotype according to the total number of Stat5 alleles that are retained. For 544 
example, two-allele Stat5a-deficient mice lack both Stat5a alleles but retain two Stat5b alleles 545 
(Stat5a-/- Stat5b+/+), while one-allele Stat5a-deficient mice lack both Stat5a alleles but retain one 546 
Stat5b allele (Stat5a-/- Stat5b+/-). Wild type and CD45.1+ C57BL/6 mice were purchased from 547 
Jackson Labs (Bar Harbor, ME). Animals were handled in accordance with NIH guidelines and 548 
all experiments approved by the NIAMS Animal Care and Use Committee. 549 
 550 
Blood, Urine & Lymphoid Tissue Analysis 551 
 552 
Complete blood counts were taken from 8-12 week old mice (NIH Clinical Center, Division of 553 
Veterinary Services, Bethesda, MD). Anti-double stranded DNA antibodies were measured in 554 
serum collected from 4-6 month old mice (Calbiotech, Spring Valley, CA). Albumin/creatinine 555 
ratio was measured in urine collected from 4-6 month old mice (Exocell, Philadelphia, PA). 556 
Spleen and lymph node (cervical, axillary, brachial and inguinal) cellularity was measured in 8-557 
12 week old mice using a Nexcelom X1 Cellometer (Lawrence, MA). 558 
 559 
Histology 560 
 561 
Kidneys were dissected from 4-6 month old mice, fixed, embedded in paraffin, sectioned and 562 
stained with hematoxylin and eosin (American Histolabs, Gaithersburg, MD). Blinded scoring 563 
was performed by a veterinary pathologist (Diagnostic & Research Services Branch, National 564 
Institutes of Health, Bethesda, MD). Specimens from at least 3 mice per genotype were 565 
inspected. Micrograph images were collected using a BioRevo BZ-9000 digital microscope 566 
(Keyence, Itasca, IL).   567 
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Flow cytometry 568 
 569 
For surface proteins, cells were stained directly ex vivo with fluorochrome labelled anti-mouse 570 
CD3ε, CD4, CD8α, CD25 (IL-2Rα), CD44, CD45R (B220), CD95 (FAS), CD127 (IL-7R), CD185 571 
(CXCR5), CD279 (PD1), GL-7, and IgD. For intracellular proteins, cells were fixed and 572 
permeabilized using Transcription Factor Staining Buffer Set (eBioscience, San Diego, CA), 573 
then stained with fluorochrome labelled anti-mouse FOXP3 and/or TBX21. For cytokine 574 
production, cells were stimulated with Phorbol 12-myristate 13-acetate and ionomycin for 4 575 
hours (50 ng/ml and 500 ng/ml, respectively; Sigma-Aldrich, St. Louis, MO), treated with 576 
Brefeldin A for 2 hours (10 μg/ml; Sigma-Aldrich), fixed (2% formaldehyde; Sigma-Aldrich), 577 
permeabilized (0.25% Saponin; Sigma/Aldrich), and stained with fluorochrome labelled anti-578 
mouse IFN-ɣ, IL-2 and/or IL-17A. For IL-2Rα induction, naive CD4+ CD44low CD25- cells were 579 
purified from pooled lymph nodes and spleens using a FACS Aria Cell Sorter (>98% purity; BD 580 
Biosciences, San Diego, CA). These were stimulated with plate-bound anti-CD3 (10 μg/ml; 581 
Clone 17A2) and soluble anti-CD28 (1 μg/ml; Clone 37.51) in the presence of soluble anti-582 
mouse IL-2, IL-4 and IFN-ɣ (10 μg/ml each; Clones S4B6, BVD6-24G2 and XMG1.2; BioXcell, 583 
West Lebanon, NH) for 18 hours, then treated with human IL-2 (100 units/ml; NIH/NCI BRB 584 
Preclinical Repository) or mouse IL-6 (20 ng/ml; eBioscience) for 18 hours and stained with 585 
fluorochrome labelled anti-mouse CD25. For tyrosine-phosphorylated STAT5, splenocytes were 586 
treated directly ex vivo with human IL-2 (100 units/ml) or mouse IL-7 (20 ng/ml; eBioscience) for 587 
1 hour, or stimulated with anti-CD3 and anti-CD28 in the presence of anti-mouse IL-2 for 18 588 
hours, then pulsed with human IL-2 for 1 hour (100 units/ml). These were then fixed with 2% 589 
formaldehyde, permeabilized with 100% methanol and stained with Alexa Fluor 647-labelled 590 
anti-human/mouse pY694 STAT5 (Clone 47; BD Biosciences) in conjunction with fluorochrome 591 
labelled anti-mouse CD3ε, CD4, CD25, CD44, CD127 and/or FOXP3. Total STAT5 protein was 592 
measured in splenocytes directly ex vivo or following retroviral transduction of purified CD4+ T 593 
cells (described below). In both cases, cells were fixed with 2% formaldehyde, permeabilized 594 
with 100% methanol, then stained with a rabbit polyclonal IgG that recognizes both STAT5A 595 
and STAT5B (sc-835; Santa Cruz Biotechnology, Santa Cruz, CA) in conjunction with 596 
fluorochrome labelled anti-mouse CD3ε, CD4, CD25, CD44, CD127, (IL-7R), CD185 (CXCR5), 597 
CD279 (PD1), IL-17A and/or FOXP3. Phycoerythrin labelled goat anti-rabbit IgG was used for 598 
detection (ac-3739; Santa Cruz Biotechnology). Normal rabbit IgG was used as a negative 599 
control (ac-2027; Santa Cruz Biotechnology). 600 
 601 
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All fluorochrome labelled antibodies were purchased from eBioscience, BD Biosciences or 602 
Biolegend (San Diego, CA), unless noted otherwise. Data was collected on a FACSverse 603 
cytometer (BD Biosciences) and analyzed using FlowJo software (FlowJo LLC, Ashland, OR). 604 
Compiled cytometry data is presented as scatter plots where each element represents a single 605 
replicate (horizontal line indicates the mean), or box plots where the the fold change for each 606 
replicate was calculated relative to WT controls and log 2 transformed (horizontal line indicates 607 
the mean and whiskers indicate minimum and maximum values). Cells were maintained in 608 
supplemented tissue culture medium (RPMI-1640 with 10% fetal calf serum, 1% sodium 609 
pyruvate, 1% nonessential amino acids, 0.1% β-Mercaptoethanol, 100 U/ml penicillin, 100 610 
mg/ml streptomycin; Life Technologies, Grand Island, NY) and cultured at a density of 0.25-0.5 611 
x 106 cells/ml in flat bottomed 96 well plates (200 ml/ well; Sigma/Costar, St. Louis, MO).  612 
 613 
T regulatory cell assays 614 
 615 
For in vitro suppression assays, CD4+ CD25high Neuropilin+ Treg cells were sorted from WT and 616 
one-allele Stat5a- or Stat5b-deficient mice. Naive, CD4+ CD44low CD25- responder cells were 617 
sorted from congenic CD45.1 mice and labelled with Carboxyfluorescein succinimidyl ester 618 
(CFSE; Sigma-Aldrich). CD11c+ antigen presenting cells (APCs) were purified from WT mice 619 
using positive selection beads (Miltenyi Biotec). 5 x 104 CD4+ responder cells were stimulated 620 
with soluble anti-mouse CD3ε (1 μg/ml) in round bottom 96 well plates containing 1 x 104 APCs 621 
and varying numbers of Treg cells, ranging from 5 x 104 (1:1 ratio) to 1.56 x 103 (1:32 ratio). 622 
After 96 hours, cells were stained with fluorochrome labelled anti-mouse CD4, CD45.1, and 623 
CD25. Percent suppression was calculated relative to WT controls and reflects the percentage 624 
of responder cells exhibiting at least one cell division. For 'Treg only' cultures, cells were 625 
stimulated with anti-CD3 and anti-CD28 in the presence human IL-2 (100 units/ml) for 72 hours. 626 
For iTreg differentiation, naive CD4+ CD44low CD25-  cells were sorted and cultured for 72 hours 627 
in the presence anti-CD3, anti-CD28, human TGF-β (10 ng/ml; R&D Systems, Minneapolis, 628 
MN), human IL-2 (100 units/ml) and anti-mouse IL-2, IL-4 and IFN-ɣ.  629 
 630 
RNA sequencing and transcriptome analysis 631 
 632 
Cell sorting was used to purify cells from pooled lymph nodes and spleens of WT and one-allele 633 
Stat5a- or Stat5b-deficient mice (>99% purity). Ex vivo groups included naive T cells (CD4+ 634 
CD44low CD25-) and Treg cells (CD4+ CD25high Neuropilin+). In vitro groups included naive T 635 
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cells that were treated with mouse IL-7 for 18 hours, effector T cells that were stimulated with 636 
anti-CD3 and anti-CD28 in the presence of human IL-2 for 72 hours, and induced Treg cells. All 637 
cultures included anti-mouse IL-2, IL-4 and IFN-ɣ (10 μg/ml each). Equal numbers of cells (0.5-638 
2.5 x 105) were collected for each replicate. These were lysed in Trizol reagent and total RNA 639 
isolated by phenol-chloroform extraction with GlycoBlue as co-precipitant (7 μg per sample; Life 640 
Technologies). Single-end libraries were prepared with 0.25-1 μg of total RNA using the TruSeq 641 
RNA Sample Preparation Kit V2 and sequenced for 50 cycles with a HiSeq 2500 instrument (4-642 
6 samples multiplexed per lane; Illumina, San Diego, CA). 50 bp reads were then mapped onto 643 
mouse genome build mm9 using TopHat and further processed using Cufflinks (Garber et al. 644 
2011). 2-3 biological replicates were sequenced per genotype for every cell type and culture 645 
condition. QC-passing read counts are presented in Supplementary File 1.  646 
 647 
Datasets are normalized based on RPKM (reads per kilobase exon model per million mapped 648 
reads) and purged of micro-RNAs, sno-RNAs and sca-RNAs. To minimize fold-change artifacts 649 
caused by low abundance transcripts, a small offset (0.2-0.3; equal to the second quartile of 650 
each dataset) was added to all RPKM values (Warden, Yuan, and Wu 2013). When multiple 651 
transcripts were detected for a single gene, only the most abundant (i.e. highest average RPKM 652 
across all 3 genotypes) was considered for downstream analyses. Transcripts with RPKM 653 
values of less than 1 in all genotypes within a given cell type or condition were excluded. Fold 654 
change and variance across genotypes and biological replicates were calculated using EdgeR 655 
(M. D. Robinson, McCarthy, and Smyth 2009). Transcripts were classified as differentially 656 
expressed if they exhibited a >1.5 fold change and significant pairwise variance (p<0.05) 657 
relative to WT controls. The 500 transcripts with greatest variance within each cell type or 658 
condition were used for multidimensional scaling (MDS) using the RobiNA software package 659 
(Lohse et al. 2012).  660 
 661 
A 'paralog preference' scale was devised to illustrate the relative impact of Stat5a - or Stat5b- 662 
deficiency. First, all transcripts that were differentially expressed in Stat5a- or Stat5b- deficient 663 
cells (relative to WT controls) were pooled to generate a single list of STAT5-regulated genes 664 
for each cell type or condition. Next, the absolute fold change was calculated and multiplied by 665 
the higher of the two RPKMs (WT or KO), thereby generating a 'paralog score'. Note that the 666 
use of absolute fold change negates the distinction between up- and down-regulated genes, 667 
while the multiplication step improves the score for high-abundance transcripts. The paralog 668 
score for STAT5B was then divided by the paralog score for STAT5A and the resulting 669 
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'preference score' was log 2 transformed so that transcripts which are more impacted by the 670 
loss of STAT5B are assigned positive values while those which are more impacted by the loss 671 
of STAT5A are assigned negative values. All transcripts were then segregated into 12 bins 672 
according to preference scores (Bin 1 includes values of less than -5, Bin 2 ranges from -5 to -4, 673 
and so on). Data are displayed as smoothed histograms and the median preference score is 674 
indicated.  675 
 676 
To identify ‘paralog specific’ transcripts, we first identified those exhibiting >1.5 fold change and 677 
significant variance (p<0.05) when comparing Stat5a- or Stat5b-deficient cells directly to one 678 
another. Next, we refined this list by stipulating that transcripts must be differentially expressed 679 
in one KO relative to WT controls (>1.5 fold change) but not in the other (<1.2 fold change). 680 
Rare transcripts with opposite expression patterns (i.e. up-regulated in one genotype but down-681 
regulated in the other) were excluded. Data are presented as pie charts.  682 
 683 
All volcano plots, XY plots, histograms and pie charts were generated with the DataGraph 684 
software suite (Visual Data Tools, Inc.). Heat maps were generated with Multi Experiment 685 
Viewer (MeV; J. Craig Venter Institute, La Jolla, CA). Genome browser files (BigWig format) 686 
were processed to remove intronic reads using TopHat and are displayed with the Integrative 687 
Genomics Viewer (IGV; Broad Institute, Cambridge, MA). 688 
 689 
GSEA analysis was performed as described (Subramanian et al. 2005). Unabridged RNA-seq 690 
datasets were used in conjunction with the following user-generated Gene Sets: 1) Treg 691 
signature genes (132 members)(Hill et al. 2007), 2) IL-2-regulated, STAT5A-dependent genes 692 
(258 members)(from the comparison of WT and 'one copy' Stat5a-deficient T cells; Figure 6), 3) 693 
IL-2-regulated, STAT5B-dependent genes (329 members)(from the comparison of WT and 'one 694 
copy' Stat5b-deficient T cells; Figure 6). Enrichment score curves and member ranks were 695 
generated by the GSEA software (Broad Institute). Normalized enrichment score (NES), false 696 
discovery rate (FDR) and nominal p Value is shown on each plot. 697 
 698 
See Supplementary File 2 for RPKM, fold change and  p values for all experimental groups 699 
and conditions, Supplementary File 3 for paralog preference calculations and Supplementary 700 
File 4 for paralog-specific genes.  701 
  702 
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Chromatin immuno-precipitation and DNA sequencing 703 
 704 
Cell sorting was used to purify naive CD4+ CD44low CD25- cells from WT, Stat5a/bhet and two-705 
allele Stat5a- or Stat5b-deficient mice (>99% purity). These were stimulated with anti-CD3 and 706 
anti-CD28 in the presence of human IL-2 for 48 hours (10 U/ml with anti-mouse IL-2, IL-4 and 707 
IFN-ɣ), then pulsed with IL-2 (100 U/ml) for one hour before fixing with 1% formaldehyde. They 708 
were then lysed (1 x 107 cells/sample), sonicated and immuno-precipated using a polyclonal 709 
rabbit anti-mouse IgG that recognizes both STAT5A and STAT5B (ab7969; Abcam, Cambridge, 710 
MA). Recovered STAT5-bound DNA fragments, along with un-precipitated ‘input controls’, were 711 
blunt-end ligated to adaptors and single-end libraries constructed using the NEBNext ChIP-Seq 712 
Library Prep for Illumina kit (New England Biolabs, Ipswich, MA). Sequencing was performed on 713 
a HiSeq 2500 instrument (50 cycles; Illumina) and short reads (50 bps) aligned using Bowtie 714 
(Langmead et al. 2009). Non-redundant reads were mapped to the mouse genome (mm9) and 715 
aggregated into peaks and using MACS 1.4.2 (Feng et al. 2012). Only peaks with >3 fold 716 
enrichment over background and p values <0.00005  were called. Positive false discovery rates, 717 
or q-values, were calculated empirically for each peak and all were below 0.2% (Storey 2003). 2 718 
biological replicates were sequenced per genotype. 'bamCorrelate' from deepTools 1.5 was 719 
used to calculate Spearman's rank correlation coefficients as a measure of inter-replicate 720 
variability (WT=0.82, Stat5a/bhet=0.83, Stat5a-deficient=0.82, Stat5b-deficient=0.81; all pairwise 721 
p-values <2.2. x 10-16)(Ramirez et al. 2014). Read depth for all replicates is presented in 722 
Supplementary File 1. 723 
 724 
Peaks were annotated to the nearest known gene using HOMER (Y. Zhang et al. 2008; Heinz et 725 
al. 2010). Localization was calculated as the percentage of peaks found within 10 kb intervals of 726 
the nearest transcriptional start sites and plotted as histograms. Direct comparison between 727 
experimental groups (i.e. peak overlap) was done with PAPST (Bible et al. 2015). Circos plot 728 
was generated by inputing the number of shared peaks between experimental groups to the 729 
Circos Table Viewer (http://mkweb.bcgsc.ca/tableviewer)(Krzywinski et al. 2009). Violin plot was 730 
generated by inputing tag numbers to the online BoxPlotR applet 731 
(http://boxplot.tyerslab.com)(Editorial 2014). Transcription factor motif analysis was done with 732 
HOMER using an 'in house' database generated by applying de novo motif discovery to 733 
published ChIP-seq datasets. Genome browser files are displayed with IGV.    734 
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ENCODE Analysis 735 
 736 
Strand-specific RNA sequencing data was generated by the ENCODE Transcriptome Group 737 
from Cold Spring Harbor Laboratories (U.S.A.) and the Center for Genomic Regulation 738 
(Spain)(https://genome.ucsc.edu/cgi-739 
bin/hgTrackUi?hgsid=424400999_9OI4vJsT1sakRAPyi9mNSC7V81zc&g=wgEncodeCshlLong740 
RnaSeq). DNAseI hyper-sensitivity data was generated by the University of Washington 741 
ENCODE group (https://genome.ucsc.edu/cgi-742 
bin/hgTrackUi?hgsid=424401115_qgaAWZ6Xs38F1laFE3UuHnvAG7AS&g=wgEncodeUwDnas743 
e). Data are used in accordance with the ENCODE data release policy (Yue et al. 2014) and 744 
visualized with the UCSC genome browser, focusing on the mouse Stat5a/b locus 745 
(chr11:100642045-100746483).   746 
 747 
Retroviral Gene Transduction 748 
 749 
Retroviral vector expressing phosphatase-insensitive STAT5A was generated as described (J. 750 
Zhu et al. 2003). Plasmids were transfected into Phoenix packaging cells using Lipofectamine 751 
(Invitrogen) and the resulting viral supernatants used to transduce CD4+ cells from WT, 752 
Stat5a/bhet  or one-allele Stat5b-deficient mice. These were stimulated (anti-CD3/CD28) in the 753 
presence of anti-mouse IL-2 for 48 hours, exposed to viral supernatant for 1 hour (at 2200 rpm, 754 
18°C), and cultured for an additional 48 hours in the presence of human IL-2 (100 U/ml). For 755 
some experiments, cells were cultured under iTreg (10 ng/ml human TGF-β) or Th17 (2.5 ng/ml 756 
human TGF-β + 20 ng/ml mouse IL-6) polarizing conditions before and after transduction (both 757 
in the presence of anti-mouse IL-4 and IFN-ɣ). For RNA-seq, 1-2 x 105 cells expressing the 758 
bicistronic transduction marker (human NGFR) were purified by cell sorting. Transcripts that 759 
were significantly impacted (>1.5 fold change, p<0.05) by ectopic STAT5A relative to empty 760 
vector were enumerated using EdgeR. 761 
 762 
Relative Paralog Measurements 763 
 764 
Transcriptome data for CD4+ naive and Treg cells was sourced from: 1) Immunological Genome 765 
Project (mouse microarrays: http://www.immgen.org), 2) EMBL-EBI Expression Atlas (mouse 766 
RNA-seq: https://www.ebi.ac.uk/gxa/experiments/E-MTAB-2582), 3) BioGPS Primary Cell Atlas 767 
(human microarrays: http://biogps.org/dataset/BDS_00013/), and 4) our RNA-seq catalogue 768 
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(described above; Figure 6). Normalized expression values (microarray signal intensity or 769 
FPKM) for Stat5a and Stat5b were first divided by one another to generate a paralog ratio which 770 
was then converted to a percentage (% total STAT5 mRNA accounted for by each paralog) and 771 
presented as pie charts.  772 
 773 
Total STAT5 protein was measured by flow cytometry in naive (CD3ε+ CD4+ CD44low IL-7R+), 774 
Treg (CD3ε + CD4+ FOXP3+), Tfh (CD3ε + CD4+ PD1+ CXCR5high) and effector/memory (CD3ε 775 
+CD4+CD44high) T cells from one- or three-allele Stat5a- or Stat5b-deficient mice, as well as 776 
Stat5a/bhet mice and WT controls. Mean fluorescence intensity (MFI) was first divided by the 777 
baseline (i.e. WT controls) to generate 'fold change' values which, in turn, were divided across 778 
Stat5a- and Stat5b-deficient genotypes bearing the same total number of alleles. The resulting 779 
paralog ratios (one for one-allele cells and one for three-allele cells) were then averaged, 780 
converted to a percentage (% total STAT5 protein accounted for by each paralog) and 781 
presented as pie charts. 782 
 783 
Statistics 784 
 785 
Unpaired ANOVA was used to quantify statistical deviation between experimental groups. In all 786 
figures, black asterisks denote significant differences (p < 0.05) between the indicated group 787 
and WT controls. Orange asterisks denote significant differences between Stat5a- and Stat5b-788 
deficient mice bearing the same total number of STAT5 alleles.     789 
 790 
Data Deposition 791 
 792 
All sequencing data have been deposited to the Gene Expression Omnibus under the accession 793 
number GSE77656.  794 
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Figure Legends 1143 
 1144 
Figure 1. Stat5b is required for immunological tolerance. (A) Cartoon depicts the mutant mice 1145 
used in this study. Genotypes are grouped according to total Stat5 alleles. (B) Bar graphs show 1146 
averaged RBC, hematocrit and WBC counts. (C) Scatter plot shows kidney pathology scores. 1147 
(D) Scatter plot shows urinary albumin/creatinine protein ratios. (E) Bar graph shows ELISA 1148 
measurements (O.D.) for anti-double stranded DNA antibodies in serum. (F) Micrographs show 1149 
representative H & E kidney sections (40X magnification). (B-E) Number of Stat5a, Stat5b and 1150 
total Stat5 alleles (i.e. genotype) is explained in the key below each graph. Data are compiled 1151 
from 3-5 mice per genotype. Error bars indicate standard deviation.  1152 
 1153 
Figure 2. Impact of STAT5 paralog deficiency on B and T cells. (A) Bar graphs show averaged 1154 
cell counts for spleens (top row) and lymph nodes (bottom row). Error bars indicate standard 1155 
deviation. (B) Percentages of CD4+ T cells (CD3+ CD4+ CD8α-), CD8+ T cells (CD3+ CD4- 1156 
CD8α+) and B cells (CD3- B220+) were measured in spleens (top row) and LNs (bottom row). 1157 
Box plots show log2 fold changes relative to wild type controls (WT=0; not shown). Dotted red 1158 
lines indicate two-fold changes. (A-B) Number of Stat5a, Stat5b and total Stat5 alleles is 1159 
explained in the key below each graph. Data are compiled from 5 experiments. (C) Contour 1160 
plots show percentages of GL7+ Fas+ germinal center B cells in lymph nodes. Scatter plot shows 1161 
percentages of LN resident GC B cells compiled from 3 experiments (3-4 mice per group). 1162 
Genotypes are ordered as in Figure 1E (WT mice = white, one-allele Stat5a-deficient mice = 1163 
blue, one-allele Stat5b-deficient mice = orange). 1164 
 1165 
 Figure 3. Aberrant effector T cell responses in the absence of Stat5b. (A) Contour plots show 1166 
percentages of CD44low IL-7R+naive and CD44high effector/memory CD4+ T cells in the spleens 1167 
of 8 week-old mice. (B) Scatter plots show percentages of naive CD4+ T cells in spleens (left) 1168 
and lymph nodes (right). Genotypes are ordered as in Figure 1C. (C) Contour plots show 1169 
percentages of IFN-ɣ+ or IL-17+ CD4+ T cells in the spleens of 8 week-old mice. (D) Box plots 1170 
show log2 fold changes for IFN-ɣ+ and IL-17+ cells relative to wild type controls (WT=0; not 1171 
shown). (E) Contour plots show percentages of PD1+ CXCR5high Tfh cells in the spleens of 8 1172 
week-old mice. (F) Box plots show log2 fold changes for Tfh cells in spleens (left) and LNs 1173 
(right) relative to wild type controls (WT=0; not shown). (D & F) Genotypes are ordered as in 1174 
Figure 1D. Data are compiled from 4 experiments (3-6 mice/group). Dotted red lines indicate 1175 
two-fold changes.   1176 
1177 
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Figure 4. T regulatory cell function is impaired in Stat5b-deficient mice. (A) Contour plots show 1178 
percentages of IL-2Rα+ cells within the FOXP3+ Treg compartment in spleens of 8 week-old 1179 
mice. (B) Box plots show log2 fold changes in the ratio of IL-2Rα+/IL-2Rα- Treg (WT=0; not 1180 
shown). LN (top) and spleen (bottom) data are compiled from 5 experiments (4-6 mice/group) 1181 
and genotypes ordered as in Figure 1D. (C) IL-2Rα+ Treg cells from WT and Stat5a- or Stat5b-1182 
deficient mice were used for in vitro suppression assays. Histograms show CFSE dilution of 1183 
responder T cells. (D) Line graph shows percent suppression across a range of responder:Treg 1184 
ratios. Baseline is set according to WT controls at a 1:1 ratio. Data are compiled from 3 1185 
experiments. (E) Line graph shows the percent Treg cells that remained IL-2Rα+ during in vitro 1186 
suppression. (F) IL-2Rα+ Treg cells were cultured with IL-2 for 72 hours. Contour plots show the 1187 
percentage of FOXP3+ Treg cells expressing TBX21 (top) or IL-2 (bottom). (G) Box plots show 1188 
log2 fold changes for TBX21+, FOXP3+ and IL-2+ cells relative to wild type controls (WT=0; not 1189 
shown). Data are compiled from 3 experiments. Dotted red lines indicate two-fold changes. 1190 
 1191 
Figure 5. Defective iTreg differentiation in the absence of Stat5b. (A) Naive CD4+ T cells were 1192 
cultured under iTreg-inducing conditions. Contour plots show percentages of FOXP3+ and IL-2+ 1193 
cells. (B) Box plots show log2 fold changes for FOXP3+ and IL-2+ cells relative to wild type 1194 
controls (WT=0; not shown). Data are compiled from 3 experiments and genotypes ordered as 1195 
in Figure 1D (C) Naive T cells from one-allele Stat5a- or Stat5b-deficient mice were cultured as 1196 
in (A) and processed for RNA-seq. GSEA plots show enrichment of Treg signature genes within 1197 
the Stat5a-deficient (top) or Stat5b-deficient (bottom) datasets relative to WT controls. (D) Heat 1198 
map shows a selection of STAT5-regulated, Treg signature transcripts. Data are presented as 1199 
log2 fold changes relative to WT controls (not shown). RNA-seq analyses are compiled from 2 1200 
biological replicates per genotype. 1201 
 1202 
Figure 6. Redundancy and specificity of STAT5 paralogs for gene transcription. (A) Cartoons 1203 
depict the cell types and experimental conditions used for RNA-seq. (B) Histograms show 1204 
STAT5 paralog preference for all STAT5-regulated transcripts. Those which were more 1205 
influenced by the loss of Stat5a are positioned to the left (X<0) while those that were more 1206 
influenced by the loss of Stat5b are positioned to the right (X>0). Dotted red lines denote 1207 
equivalence (X=0) and numbers indicate median paralog preference. (C) Pie charts depict 1208 
paralog specific transcripts. Those impacted only in Stat5a-deficient cells are indicated in blue, 1209 
those impacted only in Stat5b-deficient cells are indicated in orange and those impacted in both 1210 
genotypes are indicated in black. (D) Heat maps show a selection of STAT5-regulated 1211 
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transcripts. Data are presented as the log2 fold change relative to WT controls (not shown). (E) 1212 
IL-2Rα protein was measured in T cells treated with IL-2 (left) or IL-6 (right). Box plots show 1213 
log2 fold changes for mean fluorescence intensity relative to wild type controls (WT=0; not 1214 
shown). Genotypes are ordered as in Figure 1D. Dotted red lines indicate a two-fold change. (A-1215 
D) RNA-seq analyses are compiled from 2-3 biological replicates per genotype.  1216 
 1217 
Figure 7. Influence of paralog dose on genomic distribution of STAT5. (A) CD4+ T cells from 1218 
WT, Stat5a/bhet and two-allele Stat5a- or Stat5b-deficient mice were cultured in the presence of 1219 
IL-2, then processed for pan-STAT5 ChIP-seq. Bar graph shows the total number of STAT5-1220 
bound peaks in each genotype. (B) Histogram shows distribution of STAT5-bound peaks 1221 
relative to transcriptional start sites (TSS). (C) Circos plot shows overlap of STAT5-bound beaks 1222 
across genotypes. Connection width represents the number of overlapping peaks. Only peaks 1223 
shared with WT cells are shown. Those found only in WT cells are presented as a white semi-1224 
circle at the top. (D) Bar graph shows the percentage of WT peaks detected in each genotype 1225 
(WT=100%). Violin plot depicts the total number of sequenced tags (i.e. peak intensity) for peak 1226 
shared with WT controls. (E) Genome browser tracks show STAT5 peaks near selected genes. 1227 
Numbers indicate the maximum peak height within the interval. (A-E) Data are representative of 1228 
two biological replicates. 1229 
 1230 
Figure 8. Preservation of high affinity targets in the absence of STAT5B.  1231 
Circle plot relates STAT5 occupancy and STAT5-dependent transcription for genes bound in: 1232 
(1) only WT cells (white circle), (2) WT and Stat5a/bhet, cells (grey circle), (3) WT, Stat5a/bhet, 1233 
and Stat5a-/- cells (blue circle), (4) WT, Stat5a/bhet, Stat5a-/- and Stat5b-/- cells (orange circle).  1234 
STAT5 ChIP-seq peaks were assigned to genes based on proximity to transcriptional start sites 1235 
(+/- 10 kb). X axis denotes the average height of gene-associated peaks in WT cells. Y axis 1236 
denotes the average mRNA expression variance (-log10 p value) for the corresponding peak-1237 
associated genes. Variance is derived from the comparison WT and one-allele Stat5a- or 1238 
Stat5b-deficient cells cultured in the presence of IL-2 (from Figure 6). Size of each circle 1239 
represents the total number of gene-associated peaks in each group (number is shown).  1240 
 1241 
Figure 9. Relative abundance of STAT5A and STAT5B in helper T cells. (A) Total STAT5 1242 
protein was measured in naive, Treg, Tfh and effector/memory T cells. Donut charts indicate the 1243 
percentage of total STAT5 protein accounted for by each paralog. Histograms show 1244 
representative flow cytometry data from one of three experiments. (B) Naive, Treg and 1245 
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effector/memory T cells were treated with IL-2 or IL-7 and phospho-STAT5 measured by flow 1246 
cytometry. Box plots show log2 fold changes for the percentage of p-STAT5high cells relative to 1247 
wild type controls (WT=0; not shown). Genotypes are ordered as in Figure 1D. Dotted red lines 1248 
indicate a two-fold change (3-4 replicates/group). 1249 
 1250 
Figure 10. Paralog dose governs STAT5-driven gene transcription. (A) CD4+ T cells from one-1251 
allele Stat5b-deficient mice were transduced with STAT5A retrovirus, then processed for RNA-1252 
seq. Contour plots (left) show correlation between the transduction marker (hNGFR) and IL-2Rα 1253 
protein. Volcano plot (middle) shows log2 fold changes and variances for all transcripts relative 1254 
to control retrovirus. Those exhibiting >1.5 fold change and p<0.05 are depicted in blue. Dotted 1255 
red lines indicate 2 fold change and 0.05 p value. Histogram (right) shows STAT5 paralog 1256 
preference for transcripts mobilized by ectopic STAT5A. Dotted red line denotes equivalence 1257 
and number indicates median paralog preference. (B) Heat map shows selected transcripts in 1258 
STAT5A-transduced helper T cells (top row) or IL-2 treated Stat5a- or Stat5b-deficient cells 1259 
(bottom rows; from Figure 6). Data are presented as the log2 fold change relative to controls 1260 
(not shown). (C) GSEA plots show enrichment of STAT5A-dependent (left) or STAT5B-1261 
dependent (right) genes within the STAT5A-RV dataset.  (A-C). RNA-seq analysis is compiled 1262 
from 2 biological replicates. (D) CD4+ T cells from WT, Stat5a/bhet and one-allele Stat5b-1263 
deficient mice were transduced with control (top row) or STAT5A (bottom row) retrovirus under 1264 
iTreg polarizing conditions. Contour plots show total STAT5 and FOXP3 protein levels in 1265 
transduced cells. (E) Histograms denote IL-2Rα protein levels on transduced cells. (D-E) Shown 1266 
is one of two independent experiments. 1267 
1268 
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 Figure Supplement Legends 1269 
 1270 
Figure 3-figure supplement 1. Impact of Stat5 allele depletion on effector T cell responses. (A) 1271 
Contour plots show percentages of CD44low IL-7R+ naive and CD44high effector/memory CD4+ T 1272 
cells. (B) Contour plots show percentages of PD1+ CXCR5high T follicular helper cells. (A & B) 1273 
Data are from spleens of 8 week-old mice and are representative of 4-5 experiments. 1274 
 1275 
Figure 4-figure supplement 1. Impact of Stat5 allele depletion on Treg cells.  1276 
Bar graphs show total numbers of Treg cells in spleens and LNs of 8 week old mice (4-6 mice 1277 
per genotype). Number of Stat5a, Stat5b and total Stat5 alleles (i.e. genotype) is explained in 1278 
the key below each graph. Error bars indicate standard deviation.  1279 
 1280 
Figure 6-figure supplement 1. Transcriptomic analysis of Stat5a- and Stat5b-deficient T cells.  1281 
(A) Cartoons depict the experimental conditions used for RNA-seq. CD4+ T cells were purified 1282 
from WT and one-allele Stat5a- or Stat5b-deficient mice, then transcriptomes measured either 1283 
directly ex vivo or after in vitro treatment with acute STAT5 stimuli. The ex vivo set included 1284 
naive cells (first row) and IL-2Rα+ Treg cells (second row), while the in vitro set included naive 1285 
cells exposed to IL-7 (third row) and effector cells exposed to IL-2 (fourth row). (B) 1286 
Multidimensional scaling (MDS) plots show the overall relatedness between experimental 1287 
groups. Each biological replicate is represented by black (WT), blue (Stat5a-deficient) or orange 1288 
(Stat5b-deficient) elements. (C) Volcano plots show fold changes and variances for all 1289 
transcripts relative to WT controls. Those exhibiting >1.5 fold change and p<0.05 are 1290 
highlighted. Numbers indicate the sum of transcripts that were down-regulated (upper left) or 1291 
up-regulated (upper right) in Stat5a- or Stat5b-deficient cells. Dotted red lines are drawn at 2 1292 
fold changes and 0.05 p values. (D) Venn diagrams indicate the number of transcripts exhibiting 1293 
>1.5 fold change and <0.05 p values only in Stat5a-deficient cells (blue), only in Stat5b-deficient 1294 
cells (orange) or in both genotypes (black). (E) XY plots show log2 fold change for STAT5-1295 
regulated genes in Stat5a-deficient (x axis) versus Stat5b-deficient (y axis) cells. Blue and 1296 
orange elements represent transcripts designated as STAT5A- or STAT5B-specific, 1297 
respectively. Dotted red lines are drawn at 1.5 fold changes. (A-E) Analyses are compiled from 1298 
2-3 biological replicates per genotype.    1299 
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Figure 6-figure supplement 2. Transcriptomic analysis of Stat5a- and Stat5b-deficient T cells.  1300 
Genome browser tracks show transcript abundance in WT (grey), Stat5a-deficient (blue) or 1301 
Stat5b-deficient (orange) cells. Vertical RPKM scale varies from gene to gene (but not across 1302 
experimental conditions) and is denoted by the numbers at the upper left of each column. 1303 
Shown is one of 2-3 biological replicates per genotype. 1304 
 1305 
Figure 7-figure supplement 1. Transcription factor motifs associated with STAT5 binding 1306 
peaks.  1307 
CD4+ T cells were isolated from WT, Stat5a/bhet and two-allele Stat5a- or Stat5b-deficient mice, 1308 
then cultured in the presence of IL-2 and processed for ChIP-seq. Chart shows the top ten 1309 
transcription factor binding motifs associated with STAT5 peaks in each genotype. p Values and 1310 
enrichment (% STAT5 peaks with indicated motif ÷ % random peaks with indicated motif) are 1311 
shown for one of two biological replicates. 1312 
 1313 
Figure 7-figure supplement 2. Correlation between STAT5 binding and transcription of Il2ra, 1314 
Bcl2 and Bcl6. 1315 
(A) Effector CD4+ T cells from one-allele Stat5a- or Stat5b-deficient mice were cultured in the 1316 
presence of IL-2 and processed for RNA-seq. (B) Effector CD4+ T cells from one-allele Stat5b-1317 
deficient mice were transduced with control or STAT5A-expressing retrovirus and processed for 1318 
RNA-seq. (C) Effector CD4+ T cells from WT, Stat5a/bhet and  two-allele Stat5a- or Stat5b-1319 
deficient mice were cultured in the presence of IL-2 and processed for ChIP-seq. (A-C) Genome 1320 
browser tracks show transcript abundance or STAT5 binding for selected genes. Numbers 1321 
indicate either RPKM values for the most detected exon (RNA-seq) or maximum STAT5 binding 1322 
peak intensity within the interval (ChIP-seq). Shown is one of two biological replicates for each 1323 
genotype and/or experimental condition. 1324 
 1325 
Figure 9 (Figure Supplement 1). Relative abundance of STAT5A and STAT5B in helper T 1326 
cells. (A) Donut charts indicate the percentage total STAT5 mRNA (top) or protein (bottom) 1327 
accounted for by each paralog in ex vivo naive or Treg cells. mRNA data are compiled from 2-3 1328 
RNA-seq replicates and protein data are compiled from 3 flow cytometry replicates (B) Donut 1329 
charts indicate the percentage total STAT5 mRNA accounted for by each paralog in mouse 1330 
naive or Treg cells. Data were sourced from the Immunological Genome Project (top) or the 1331 
EMBL-EBI Expression Atlas (bottom). (C) Donut charts indicate the percentage total STAT5 1332 
mRNA accounted for by each paralog in human naive or Treg cells. Data were sourced from the 1333 
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BioGPS Primary Cell Atlas.  1334 
1335 
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Figure 9-figure supplement 2. Stat5a and Stat5b are transcribed from opposite DNA strands. 1336 
Genome browser tracks show relative abundance and DNA strand origin of Stat5a and Stat5b 1337 
mRNAs within mouse spleen, thymus and mammary gland. Transcripts originating from the 1338 
minus (-) strand are presented in the ascending orientation while those from the plus (+)  strand 1339 
are in the descending orientation. Numbers indicate RNA-seq FPKM values for the most 1340 
detected exon within the interval. Data are sourced from the ENCODE consortium and one of 2 1341 
biological replicates visualized using the UCSC genome browser.  1342 
 1343 
Figure 9-figure supplement 3. Putative lymphocyte-restricted enhancers within the Stat5a/b 1344 
locus. 1345 
Genome browser tracks display DNAse I hypersensitivity sites (DHS) within the mouse Stat5a/b 1346 
locus. Shown are data for primary CD4+ T cells (naive, activated, Treg), as well as spleen, 1347 
thymus and multiple non-lymphoid tissues. 3 putative lymphoid-specific DHS sites are 1348 
highlighted. Numbers indicate maximum tag count for all DHS sites within the interval. Data are 1349 
sourced from the ENCODE consortium and one of 2 biological replicates visualized using the 1350 
UCSC genome browser.  1351 
 1352 
Figure 10-figure supplement 1. STAT5 paralog dose tips the balance between effector and 1353 
regulatory T cell programs. CD4+ T cells from WT, Stat5a/bhet and one-allele Stat5b-deficient 1354 
mice were were transduced with control or STAT5A retrovirus under (A) non-polarizing or (B) 1355 
Th17-polarizing conditions. Contour plots denote FOXP3 and IL-17A protein levels in 1356 
transduced cells. Shown is one of two independent experiments.  1357 
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Supplementary File Legends 1358 
 1359 
Supplementary File 1. Read depth for sequencing experiments. Spreadsheet reports QC-1360 
passing reads for all RNA-seq and ChIP-seq experiments. 1361 
 1362 
Supplementary File 2. RPKM values for transcriptome analysis of STAT5-deficient CD4+ T 1363 
cells. Spreadsheet includes RPKM values for all experimental groups and biological replicates. 1364 
 1365 
Supplementary File 3. Paralog preference calculations for STAT5-deficient CD4+ T cells. 1366 
Spreadsheet includes paralog preference calculations for all relevant cell types and 1367 
experimental conditions. 1368 
 1369 
Supplementary File 4. STAT5 paralog-specific genes. Spreadsheet lists STAT5 paralog-1370 
specific genes for all relevant cell types and experimental conditions. 1371 










